ClinicalTrials.Veeva

Menu

A Double Blind Crossover Study on the Effect of Methylphenidate on Decision-making Ability of Adults With ADHD Compared to Healthy Adults

S

Shalvata Mental Health Center

Status

Unknown

Conditions

ADHD

Treatments

Drug: methylphenidate

Study type

Interventional

Funder types

Other

Identifiers

NCT01124032
SHA 01-10

Details and patient eligibility

About

The study assesses the effect of Ritalin on working memory,attention,and decision-making measures in adults with ADHD and compares it to its effect on healthy adults, in a double-blind crossover design.We hypothesize that Ritalin will result in better performance in all measures,and that the improvement will be greater in the ADHD group.

Enrollment

30 estimated patients

Sex

All

Ages

21 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adults in the age of 21-50

Exclusion criteria

  1. People diagnosed with a clinical disorder other than ADD/ADHD that may impair their performance in the tasks used in the study.
  2. People for whom there is a contra-indication for consuming Ritalin.
  3. Pregnant women and nursing women;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

30 participants in 2 patient groups

ADHD adults
Experimental group
Treatment:
Drug: methylphenidate
healthy adults
Experimental group
Treatment:
Drug: methylphenidate

Trial contacts and locations

1

Loading...

Central trial contact

Ziv Carmel, MD; Nirit Agay, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems